Guangzhou Bioseal Biotechnology Co., Ltd.   Report issue

For profit Phase 4
Founded: Guangzhou China (1995)

Organization Overview

First Clinical Trial
2013
NCT02034799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

human fibrin (Tisseel) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 4)

Meningioma (Phase 4)

Neoplasms (Phase 3)

Vascular Malformations (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 1